Streetbeat News

Price Targets

CNTA

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy rating and announces a price target of $9.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:22 am

AMD

Rosenblatt analyst Hans Mosesmann reiterated a Buy rating on Advanced Micro Devices (NASDAQ:AMD) and maintained a $200 price target.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:17 am

JSPR

EF Hutton analyst Michael King reiterated a Buy rating on Jasper Therapeutics (NASDAQ:JSPR) and maintained a $6.85 price target.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:15 am

KE

EF Hutton analyst Tim Moore initiates coverage on Kimball Electronics (NASDAQ:KE) with a Buy rating and announces a price target of $37.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:14 am

BIIB

Needham analyst Ami Fadia reiterates a Buy rating on Biogen (NASDAQ:BIIB) and maintains a $321 price target.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:12 am

BCOV

Rosenblatt analyst Steve Frankel reiterates a Buy rating on Brightcove (NASDAQ:BCOV) and maintains a $9 price target.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:11 am

NXST

Rosenblatt analyst Barton Crockett has reiterated a Buy rating on Nexstar Media Gr (NASDAQ:NXST) and maintained a $228 price target.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:10 am

EXTR

Rosenblatt analyst Mike Genovese maintains a Buy rating on Extreme Networks (NASDAQ:EXTR) and raises the price target from $23 to $30.

Portfolio Pulse from richadhand@benzinga.com

June 12, 2023 | 11:09 am

NIO

NIO Inc reported Q1 FY23 sales growth of 7.7% YoY, missing consensus estimates. The company expects a decline in Q2 revenue and announced price cuts on all new models. Analysts from B of A Securities, JP Morgan, and Citigroup have lowered their price targets on NIO.

Portfolio Pulse from Lisa Levin

June 12, 2023 | 11:06 am

BILL

Needham analyst Scott Berg reiterated a Buy rating on BILL Holdings (NYSE:BILL) and maintained a $200 price target.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 10:51 am